Paris Hilton Partners with Collegium to Launch ADHD Awareness Campaign
Event summary
- Collegium Pharmaceutical and Paris Hilton launched the 'Embrace Your Sparkle' campaign on March 3, 2026, to raise awareness about ADHD.
- Paris Hilton shared her personal experience with ADHD and her use of JORNAY PM for symptom management.
- JORNAY PM is an extended-release medication designed for evening administration to support ADHD symptom management throughout the day.
- The campaign aims to reframe stereotypes and encourage open dialogue about ADHD.
The big picture
Collegium Pharmaceutical's partnership with Paris Hilton underscores a strategic shift towards patient-centric marketing in the neuropsychiatry space. The campaign aligns with broader industry trends of leveraging influencer partnerships to destigmatize mental health conditions and drive medication adherence. With ADHD affecting millions of adults and children in the U.S., Collegium aims to position JORNAY PM as a key player in the evening-dosed ADHD treatment segment.
What we're watching
- Campaign Impact
- How the 'Embrace Your Sparkle' campaign will affect ADHD awareness and Collegium's brand perception.
- Market Positioning
- Whether Collegium can leverage celebrity partnerships to differentiate JORNAY PM in the competitive ADHD treatment market.
- Regulatory Compliance
- The pace at which Collegium can navigate regulatory hurdles associated with ADHD medication marketing and patient education.